AbbVie(DE:4AB)
€266.60-1.50 (-0.56%)
DE:4AB
AbbVie earnings date
€266.60
At close:-1.50 (-0.56%)
AbbVie (4AB) Q3 2022 Earnings Report
28 Followers
DE:4AB Q3 2022 EPS Results
- Actual EPS
- EUR 3.28
- Consensus EPS
- EUR 3.20
- Beat/Miss
- Beat by +EUR 0.08
- One Year Ago EPS
- EUR 2.98
DE:4AB Q3 2022 Revenue Results
- Actual Revenue
- EUR 13.26B
- Expected Revenue
- EUR 13.39B
- Beat/Miss
- Missed by -EUR 132.54M
- YoY Revenue Growth
- +3.28%
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 10/28/2022
- Time
- Before Open
- Conference Call
- Friday, October 28, 2022
DE:4AB Upcoming Earnings
AbbVie's next earnings date is estimated for February 3, 2027, based on past reporting schedules.
Q3 2022 Earnings Call Audio
DE:4AB Q3 2022 Earnings Call
0:00 / 0:00
Q3 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:4AB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 03, 2027 | 2026 (Q4) | 3.48- | 2.43 | ― | ― |
| Oct 30, 2026 | 2026 (Q3) | 3.343.42 | 1.67 | 105.38% (+1.75) | |
| Jul 31, 2026 | 2026 (Q2) | 3.233.27 | 2.66 | 22.90% (+0.61) | |
| Apr 29, 2026 | 2026 (Q1) | 2.322.37 | 2.2 | 7.72% (+0.17) | |
| Feb 04, 2026 | 2025 (Q4) | 2.382.43 | 1.93 | 25.46% (+0.49) | |
| Oct 31, 2025 | 2025 (Q3) | 1.581.67 | 2.69 | -38.00% (-1.02) | |
| Jul 31, 2025 | 2025 (Q2) | 2.582.66 | 2.37 | 12.08% (+0.29) | |
| Apr 25, 2025 | 2025 (Q1) | 2.132.20 | 2.07 | 6.49% (+0.13) | |
| Jan 31, 2025 | 2024 (Q4) | 1.891.93 | 2.5 | -22.58% (-0.56) | |
| Oct 30, 2024 | 2024 (Q3) | 2.612.69 | 2.64 | 1.69% (+0.04) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
